JP2022169350A - 免疫賦活剤 - Google Patents

免疫賦活剤 Download PDF

Info

Publication number
JP2022169350A
JP2022169350A JP2021075330A JP2021075330A JP2022169350A JP 2022169350 A JP2022169350 A JP 2022169350A JP 2021075330 A JP2021075330 A JP 2021075330A JP 2021075330 A JP2021075330 A JP 2021075330A JP 2022169350 A JP2022169350 A JP 2022169350A
Authority
JP
Japan
Prior art keywords
cells
strain
immunostimulant
lactobacillus casei
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021075330A
Other languages
English (en)
Japanese (ja)
Inventor
友恵 中村
Tomoe Nakamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Gas Chemical Co Inc
Original Assignee
Mitsubishi Gas Chemical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Gas Chemical Co Inc filed Critical Mitsubishi Gas Chemical Co Inc
Priority to JP2021075330A priority Critical patent/JP2022169350A/ja
Priority to CN202210413708.4A priority patent/CN115245564A/zh
Publication of JP2022169350A publication Critical patent/JP2022169350A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
JP2021075330A 2021-04-27 2021-04-27 免疫賦活剤 Pending JP2022169350A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021075330A JP2022169350A (ja) 2021-04-27 2021-04-27 免疫賦活剤
CN202210413708.4A CN115245564A (zh) 2021-04-27 2022-04-15 免疫刺激剂

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2021075330A JP2022169350A (ja) 2021-04-27 2021-04-27 免疫賦活剤

Publications (1)

Publication Number Publication Date
JP2022169350A true JP2022169350A (ja) 2022-11-09

Family

ID=83698212

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021075330A Pending JP2022169350A (ja) 2021-04-27 2021-04-27 免疫賦活剤

Country Status (2)

Country Link
JP (1) JP2022169350A (zh)
CN (1) CN115245564A (zh)

Also Published As

Publication number Publication date
CN115245564A (zh) 2022-10-28

Similar Documents

Publication Publication Date Title
JP5261617B2 (ja) 新規乳酸菌、並びに新規乳酸菌を含有する医薬、飲食品、及び飼料
WO2015004949A1 (ja) 新規乳酸菌、並びに新規乳酸菌を含有する医薬、飲食品、及び飼料
JP4942831B2 (ja) 抗アレルギー用組成物
JP6524468B2 (ja) 乳酸菌が産生するエキソポリサッカライド
CA2567976C (en) A composition having immunoregulating activities comprising lactobacillus pentosus
JP6337262B2 (ja) 耐塩性乳酸菌、耐塩性乳酸菌の培養方法、及び免疫賦活剤
RU2415920C2 (ru) Применение специфических молочнокислых бактерий для получения композиции, пригодной для стимуляции иммунного ответа при заболеваниях, связанных с изменениями в иммунной системе
WO2014129599A1 (ja) 免疫賦活剤
JP7436358B2 (ja) 母乳成分増強用組成物
EP3016673B1 (en) Mammalian milk osteopontin for enhancing immune responsiveness
JP5646124B1 (ja) 新規乳酸菌、並びに新規乳酸菌を含有する医薬、飲食品、及び飼料
JP7358002B2 (ja) バチルス属細菌、インターロイキン－２２産生誘導剤、皮膚バリア機能増強剤
JP2010132579A (ja) 免疫調節機能を有する乳酸菌
JP2022169350A (ja) 免疫賦活剤
KR20200046201A (ko) 비피도박테리움 애니멀리스 서브스페시스 락티스 HY8002와 비피도박테리움 아돌레센티스 HY8502의 유산균 조합을 이용한 진세노사이드 Rd가 강화된 발효홍삼 농축액을 유효성분으로 함유하는 알레르기성 비염을 개선하기 위한 조성물
JP4851765B2 (ja) 免疫機能調節剤
JP2023023981A (ja) 生体内のＩｇＡとＩＦＮ－γ産生を促進する乳酸菌製剤及び経口組成物
JP2021182890A (ja) 免疫機能向上用組成物
JP6016326B2 (ja) 乳酸菌のスクリーニング方法
JP6999061B1 (ja) 免疫賦活用組成物、風邪様症状予防剤、及びウイルス感染予防剤
JP7488573B2 (ja) マクロファージ活性剤
JP7013419B2 (ja) 炎症性サイトカインの産生誘導活性は低いが抗炎症性サイトカインの産生誘導活性が高いビフィズス菌
JP5761679B2 (ja) パパイア発酵物を有効成分とする末梢血単核球細胞の活性調節用組成物
JP2018016580A (ja) 免疫賦活組成物
KR20240006134A (ko) 마이코박테리움 파라고르도네를 포함하는 면역 증강용 조성물